These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34327391)

  • 21. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
    Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
    Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
    Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
    J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
    Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
    Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1).
    Jarrah M; Hammoudeh A; Okkeh O; Khader Y; Gharaibeh S; Nasser L; Rasheed A; Al-Hindi A; Mohealdeen M; Kharabsheh H; Abunimeh H; Hijjih E; Tashman L; Omar D; Kufoof N;
    Anatol J Cardiol; 2017 Jun; 17(6):445-451. PubMed ID: 28344216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study.
    Liu X; Liu C; Chen X; Wu W; Lu G
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):538-43. PubMed ID: 27297558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism risk factors and prophylaxis of elderly intensive care unit patients in a Chinese general hospital.
    Chen X; Huang J; Liu J; Deng H; Pan L
    Ann Palliat Med; 2021 Apr; 10(4):4453-4462. PubMed ID: 33894730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
    Barclay SM; Jeffres MN; Nguyen K; Nguyen T
    Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive role of CHA2DS2-VASc score between venous thromboembolism and ischemic stroke: a large-scale cohort study.
    Hu WS; Lin CL
    J Hypertens; 2018 Mar; 36(3):628-633. PubMed ID: 28858980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.
    Klok FA; Barco S; Turpie AGG; Haas S; Kreutz R; Mantovani LG; Gebel M; Herpers M; Bugge JP; Kostantinides SV; Ageno W
    Br J Haematol; 2018 Nov; 183(3):457-465. PubMed ID: 30123981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
    Hlavacek P; Guo JD; Rosenblatt L; Keshishian A; Russ C; Mardekian J; Ferri M; Poretta T; Yuce H; McBane R
    Curr Med Res Opin; 2019 Dec; 35(12):2043-2051. PubMed ID: 31387467
    [No Abstract]   [Full Text] [Related]  

  • 31. The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients.
    Tsaplin S; Schastlivtsev I; Zhuravlev S; Barinov V; Lobastov K; Caprini JA
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1371-1381.e4. PubMed ID: 33744497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Venous thromboembolism risk and prophylaxis status of cancer inpatient].
    Xu RH; Shi YK; Gao Y; Li WM; Qin XY; Qu JM; Zhai ZG; Wang C
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1100-1104. PubMed ID: 34695902
    [No Abstract]   [Full Text] [Related]  

  • 33. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative Joint Replacement Complications in Swedish Patients With a Family History of Venous Thromboembolism.
    Zöller B; Svensson PJ; Sundquist J; Sundquist K; Pirouzifard M
    JAMA Netw Open; 2018 Sep; 1(5):e181924. PubMed ID: 30646144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
    Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
    Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
    Brown JD; Goodin AJ; Lip GYH; Adams VR
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Nendaz M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Jäger K; Righini M; Bounameaux H
    Thromb Haemost; 2014 Mar; 111(3):531-8. PubMed ID: 24226257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
    Forster R; Stewart M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.